Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center

Congratulations to our Interdisciplinary Translational Project team at GreenMark Biomedical Inc on their recent publication! #NIDCR #NIH #MPWRM #Innovation #TranslationalResourceCenter

We're excited to share some highlights from our 5th DOCTRC Retreat, held for the first time in Bethesda, MD, where a dynamic group of innovators, sponsors, and guests gathered to advance the future of dental, oral, and craniofacial tissue regeneration and reconstruction.  Some highlights from the event: - The event kicked off with inspiring opening remarks from Dr. Jennifer Webster-Cyriaque, Acting Director - National Institute of Dental and Craniofacial Research (NIDCR) and NIDCR Deputy Director, and Drs. David Kohn and Yang Chai from DOCTRC leadership. - Interdisciplinary Translational Project (ITP) teams from DOCTRC shared their experiences and learnings from their product development journeys, and participants shared their insights on the topics in the breakout sessions. - ITP teams presented progress updates, showcasing how they are advancing their technologies closer to positively impacting patient care. Congratulations to MPW ITP teams: Amend Surgical, Inc., Luiz Bertassoni, Pamela Yelick, GreenMark Biomedical Inc, Isabelle Lombaert, Ostiio, RevBio, Inc., Juan Taboas A sincere thank you to all participants and organizers, both in-person and online, for making this event a success.  Special thanks to our sponsor, National Institute of Dental and Craniofacial Research (NIDCR), whose vision and steadfast support have enabled DOCTRC to advance pioneering technologies to revolutionize dental, oral, and craniofacial healthcare. #MPWRM #NIDCR #NIH #translationalresearch #regenerativemedicine #InnovationInDentistry

Attention biotech innovators! 🌟 Looking to speed up your startup with #SBIR or #STTR funding? Join us on Sept. 10 for a free webinar where NCATS experts will dive into #FundingOpportunities specifically for life sciences startups. Plus, get a sneak peek into the dynamic #Houstonbiotech ecosystem from the University of Houston and the Texas Medical Center Innovation Factory. Secure your spot and get ready to take your innovation to the next level! Register here: https://lnkd.in/emEKik-h #NCATSsbir #webinar #SmallBusiness

This week, Brian Hess, CEO of RevBio, Inc., joined Dr. Giuseppe Intini and Dr. Roberta Di Carlo at the International Space Station National Laboratory Research & Development Conference in Boston. Dr. Intini delivered a compelling presentation on the topic of bone regeneration in space vs. here on earth. The research Dr. Intini presented provided the groundwork for how RevBio’s innovative bone adhesive, TETRANITE®, can aid in bone regeneration and counteract the bone loss that astronauts experience during space missions. Astronauts routinely are subjected to substantial “premature osteoporosis” due to the microgravity conditions they encounter in space. Bone density in their hips and spine has been recorded to decline by up to 2% per month. As a result, the International Space Station provides a unique lab to test treatments targeted at patients with osteoporosis. Dr. Intini’s presentation also highlighted initial findings from RevBio’s most recent experiment conducted on the International Space Station in collaboration with the Intini Lab at the University of Pittsburgh. This research will assess the rate and quality of new bone formation in mice treated with TETRANITE that subsequently were exposed to microgravity for a significant period of time while onboard the International Space Station. Stay tuned for more updates on the results from TETRANITE’s space mission in the coming months. #TETRANITE #BoneAdhesive #SpaceTravel #biomedical #engineering #osteoporosis #researchanddevelopment #regenerativemedicine #bonedensity #ISSRDC2024 #RevBio

We are pleased to share an article by one of our previous ITP teams, led by Dr. Feinberg: https://lnkd.in/ecbHVrUa #MPWRM #translationalresearch #regenerativemedicine #NIH #NIDCR

The industry recognition for our novel bone adhesive keeps coming in! RevBio was featured in the most recent issue of Orthopedic Design & Technology Magazine for their article on orthobiologicss and how novel regenerative cell therapies like TETRANITE® are radically impacting patient healing.    “TETRANITE isn’t just a glue. It’s a regenerative material that can immediately bond bone fragments to boost metal hardware strength and fill gaps in bones. It acts as a scaffold to encourage new bone growth and integrates into the body’s natural healing process. It’s injectable, self-sets, is biocompatible, has bone regenerative capabilities, and touts strength comparable to natural bone”, says RevBio CEO Brian Hess.   Learn more about how RevBio is transforming bone repair for both patients and clinicians by reading the full article, here:  https://lnkd.in/dBd9bTnJ #RevBio #TETRANITE #BoneAdhesive #Fixation #RegenerativeMedicine #BoneRegeneration #Biomimetic #Biomimicry #LifeSciences #Biotech #Biomedical #dental #orthopaedics #orthopedics #BoneGrowth #BoneRepair #biocompatible #patients #clinicians

We are pleased to share an interesting podcast! NIH All About Grants Podcast: Milestone Driven Awards - A Go/No Go Proposition This episode of the NIH All About Grants podcast series focuses on these phased/milestone-driven awards. Dr. Craig Hopp, Deputy Director of the Division of Extramural Research within the National Center for Complementary and Integrative Health, joins us for this conversation. He will help explain more about what makes these awards unique, advice on writing milestones, what peer reviewers and NIH program staff consider, how to show progress meeting the milestones, and much more. Click here to listen: https://lnkd.in/eBMStAPq #NIH #translationalresearch #podcasts #MPWRM

We are pleased to share that one of our ITPs, Dr. Bertassoni, is featured in the Portland Tribune. You can read more about his work in the article below: https://lnkd.in/gicsPbW8 #regenerativemedicine #mpwrm #nih #NIDCR

We are pleased to share that GreenMark Biomedical Inc and Dentulu Inc have partnered paving the way for the introduction of a first product, CrystLCare™ Biorestorative, Fluoride-Free, in a GreenMark-Dentulu co-branded product line. You may read more about this exciting strategic alliance in the below press release: https://lnkd.in/gEdj4Hr3   #translationalresearch #MPWRM #greenmarkbiomedical #dentulu 

Congratulations to our Interdisciplinary Translational Project team at Amend Surgical, Inc. for submitting a 510(k) on their Tissue Tape product! #NIDCR #NIH #MPWRM #Innovation